AFP and hepatocellular carcinoma: AFP is a well-known biomarker of hepatocellular carcinoma (HCC) and germ cell tumors [4, 5] In addition, it can often increase in acute or chronic liver injury and regeneration [6–9], and rarely in stomach, pancreas, and colon cancers.